Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging
- 20 November 2003
- journal article
- research article
- Published by Elsevier in NeuroImage
- Vol. 21 (1) , 229-235
- https://doi.org/10.1016/j.neuroimage.2003.08.028
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Steele‐Richardson‐Olszewski‐Syndrome: Reduction of dopamine D2 receptor binding relates to the severity of midbrain atrophy in vivo: 123IBZM SPECT and MRI studyMovement Disorders, 2002
- Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findingsZeitschrift für Neurologie, 2001
- Diffusion- and magnetisation transfer-weighted MRI in childhood moya-moyaNeuroradiology, 1998
- Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PETMovement Disorders, 1998
- Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopyAnnals of Neurology, 1995
- Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's diseaseAnnals of Neurology, 1993
- Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C‐raclopride and positron emission tomographyAnnals of Neurology, 1992
- Differing patterns of striatal 18F‐dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsyAnnals of Neurology, 1990
- Multi‐center study of Parkinson mortality with early versus later dopa treatmentAnnals of Neurology, 1987
- SUBCORTICAL DEMENTIABrain, 1985